John Trizzino
President bij NOVAVAX, INC.
Vermogen: 133 706 $ op 31-03-2024
Profiel
De heer John J. Trizzino is CFO, EVP, Chief Commercial & Business Officer bij Novavax, Inc. De heer Trizzino was eerder werkzaam als Chief Executive Officer & Director bij ImmunoVaccine, Inc., als Vice President-Vaccine Franchise bij MedImmune LLC, als Vice President-Business Development bij ID Biomedical Corp., en als Vice President-Business Development bij Henry Schein, Inc. Hij zat ook in de raad van bestuur van Tech Council of Maryland, Inc. Hij behaalde zijn doctoraal aan de Long Island University en een MBA aan de Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NOVAVAX, INC.
0.02% | 10-03-2024 | 27 972 ( 0.02% ) | 133 706 $ | 31-03-2024 |
Actieve functies van John Trizzino
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVAVAX, INC. | President | 20-11-2023 |
Eerdere bekende functies van John Trizzino
| Bedrijven | Functie | Einde |
|---|---|---|
| IMV INC. | Chief Executive Officer | 01-09-2013 |
| NOVAVAX, INC. | Corporate Officer/Principal | 06-09-2011 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01-01-2009 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01-01-2009 |
| HENRY SCHEIN, INC. | Corporate Officer/Principal | 01-01-2004 |
Opleiding van John Trizzino
| Long Island University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| HENRY SCHEIN, INC. | Distribution Services |
| NOVAVAX, INC. | Health Technology |
| IMV INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
